Orthofix Medical Inc. (OFIX)

Market Cap	619.61M
Revenue (ttm)	760.05M
Net Income (ttm)	-126.48M
Shares Out	37.53M
EPS (ttm)	-3.38
PE Ratio	n/a
Forward PE	20.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	224,857
Open	16.75
Previous Close	16.51
Day's Range	16.21 - 16.92
52-Week Range	9.57 - 21.60
Beta	1.05
Analysts	Buy
Price Target	18.00 (+9.03%)
Earnings Date	Aug 6, 2024

About OFIX

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 1,634
• Stock Exchange: NASDAQ
• Ticker Symbol: OFIX

Financial Performance

In 2023, OFIX's revenue was $746.64 million, an increase of 62.06% compared to the previous year's $460.71 million. Losses were -$151.40 million, 666.6% more than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for OFIX stock is "Buy." The 12-month stock price forecast is $18.0, which is an increase of 9.03% from the latest price.

Price Target

$18.0

(9.03% upside)

Analyst Consensus: Buy